4-AminopyridineAminopyridinesPotassium Channel BlockersTetraethylammoniumTetraethylammonium CompoundsPotassium ChannelsAdministration, OralMembrane PotentialsPotassium Channels, Voltage-GatedPotassiumCharybdotoxinAction PotentialsDose-Response Relationship, DrugRats, Sprague-DawleyRats, WistarElectrophysiologyPatch-Clamp TechniquesDelayed Rectifier Potassium ChannelsKv1.5 Potassium ChannelBarium CompoundsElapid VenomsNeuromuscular Depolarizing AgentsTime FactorsApaminBariumTetrodotoxinCalciumDrug Administration ScheduleElectric ConductivityInjections, IntravenousUnited States Food and Drug AdministrationCesiumGlyburideDrug Administration RoutesGuinea PigsNeuronsQuinidineElectric StimulationPotassium Channels, Calcium-ActivatedDogsKv1.4 Potassium ChannelIon ChannelsHippocampusCalcium Channel BlockersScorpion VenomsShaw Potassium ChannelsDisease Models, AnimalRats, Inbred StrainsAdministration, IntranasalQuinineDrug InteractionsIon Channel GatingMice, Inbred C57BLInjections, IntraperitonealCells, CulturedVasodilationKv1.1 Potassium ChannelVasodilator AgentsKineticsAcetylcholineSynaptic TransmissionRabbitsConvulsantsChromatography, High Pressure LiquidMuscle, Smooth, VascularShab Potassium ChannelsPyridostigmine BromideInjections, SubcutaneousEndothelium-Dependent Relaxing FactorsKv1.2 Potassium ChannelEnzyme InhibitorsAnimals, NewbornQuinoxalinesPyridinesMicroelectrodesAdministration, RectalHeartLiverTubocurarineSeizuresCarbohydrate SequenceMuscle RelaxationBiological AvailabilityProcaineCadmiumEvoked PotentialsShal Potassium ChannelsCromakalimShaker Superfamily of Potassium ChannelsNitric OxidePulmonary Stretch ReceptorsVerapamilInjections, IntramuscularAdministration, TopicalBlood PressureVasoconstrictionSodiumNeuromuscular JunctionInfusions, IntravenousHalf-Life